Coherus BioSciences, Inc. today announced the appointment to its Board of Directors of biopharma commercialization and market access expert Michael Ryan, Pharm. D. Dr. Ryan.

The National Pharmaceutical Council (NPC) today announced that Michael L. Ryan, PharmD, Senior Vice President, Worldwide Value, Access, Pricing and Health Economics and Outcomes Research at Bristol Myers Squibb (BMS), has been elected Chair of NPC’s Board of Directors for 2020-2021.